Postmortem interval effect on RNA and gene expression in human brain tissue

Cell and Tissue Banking

Volumn 12, Issue 4, 2011, Pages 311-318

  Birdsill, Alex C ^a   Walker, Douglas G ^a   Lue, Lih Fen ^a   Sue, Lucia I ^a   Beach, Thomas G ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Brain; Gene expression; Methods; Neurological disease; Postmortem; Research; RIN; RNA

Indexed keywords

MESSENGER RNA; RNA;

AGED; ARTICLE; BRAIN; CADAVER; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

AGED; AGED, 80 AND OVER; BRAIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; POSTMORTEM CHANGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS;

EID: 84855679762     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-010-9210-8     Document Type: Article

References (40)

1. Barrachina M, Castano E, Ferrer I (2006) TaqMan PCR assay in the control of RNA normalization in human postmortem brain tissue. Neurochem Int 49:276-284 (Pubitemid 43996868)
2. Bauer M, Gramlich I, Polzin S, Patzelt D (2003) Quantification of mRNA degradation as possible indicator of postmortem interval-a pilot study. Leg Med (Tokyo) 5:220-227 (Pubitemid 37420093)
3. Beach TG, Sue LI, Walker DG, Roher AE, Lue L, Vedders L, Connor DJ, Sabbagh MN, Rogers J (2008) The Sun Health Research Institute Brain Donation Program: Description and experience, 1987-2007. Cell Tissue Bank 9:229-245
4. Broniscer A, Baker JN, Baker SJ, Chi SN, Geyer R, Morris EB and Gaijar A (2010) Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer (Epub ahead of print, June 29, 2010
5. Buesa C, Maes T, Subirada F, Barrachina M, Ferrer I (2004) DNA chip technology in brain banks: Confronting a degrading world. J Neuropathol Exp Neurol 63: 1003-1014 (Pubitemid 39372585)
6. Burke WJ, O'Malley KL, Chung HD, Harmon SK, Miller JP, Berg L (1991) Effect of pre- and postmortem variables on specific mRNA levels in human brain. Brain Res Mol Brain Res 11:37-41
7. Castensson A, Emilsson L, Preece P, Jazin EE (2000) Highresolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res 10:1219-1229
8. Cummings TJ, Strum JC, Yoon LW, Szymanski MH, Hulette CM (2001) Recovery and expression of messenger RNA from postmortem human brain tissue. Mod Pathol 14:1157-1161 (Pubitemid 33063210)
9. Dickson DW (2005) Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol (Berl) 109:14-24 (Pubitemid 40287786)
10. Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D, Smith C, Walker R, Al-Sarraj S, Troakes C, Palkovits M, Kasztner M, Huitinga I, Arzberger T, Dexter DT, Kretzschmar H, Reynolds R (2010) Effects of antemortem and postmortem variables on human brain mRNA quality: A BrainNet Europe study. J Neuropathol Exp Neurol 69:70-81
11. Eastwood SL, Burnet PW, McDonald B, Clinton J, Harrison PJ (1994) Synaptophysin gene expression in human brain: A quantitative in situ hybridization and immunocytochemical study. Neuroscience 59:881-892 (Pubitemid 24149098)
12. Ervin JF, Heinzen EL, Cronin KD, Goldstein D, Szymanski MH, Burke JR, Welsh-Bohmer KA, Hulette CM (2007) Postmortem delay has minimal effect on brain RNA integrity. J Neuropathol Exp Neurol 66:1093-1099 (Pubitemid 350294659)
13. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33-39 (Pubitemid 29046907)
14. Gilmore JH, Lawler CP, Eaton AM, Mailman RB (1993) Postmortem stability of dopamine D1 receptor mRNA and D1 receptors. Brain Res Mol Brain Res 18:290-296
15. Grunblatt E, Monoranu CM, Apfelbacher M, Keller D, Michel TM, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, McLean C, Halliday GM, Harper C, Deckert J, Roggendorf W, Riederer P (2009) Tryptophan is a marker of human postmortem brain tissue quality. J Neurochem 110:1400-1408
16. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC (1995) The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200:151-154
17. Johnson SA, Morgan DG, Finch CE (1986) Extensive postmortem stability of RNA from rat and human brain. J Neurosci Res 16:267-280 (Pubitemid 16050423)
18. Johnston NL, Cervenak J, Shore AD, Torrey EF, Yolken RH (1997) Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods 77:83-92 (Pubitemid 27488092)
19. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28:311-318
20. Leonard S, Logel J, Luthman D, Casanova M, Kirch D, Freedman R (1993) Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatr 33:456-466 (Pubitemid 23149167)
21. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, Mesarwi O, Jones EG, Watson SJ, Akil H, Bunney WE Jr, Myers RM (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13:609-616 (Pubitemid 38379850)
22. Lukiw WJ, Wong L, McLachlan DR (1990) Cytoskeletal messenger RNA stability in human neocortex: Studies in normal aging and in Alzheimer's disease. Int J Neurosci 55:81-88
23. Mathern GW, Pretorius JK, Kornblum HI, Mendoza D, Lozada A, Leite JP, Chimelli L, Born DE, Fried I, Sakamoto AC, Assirati JA, Peacock WJ, Ojemann GA, Adelson PD (1998) Altered hippocampal kainate-receptor mRNA levels in temporal lobe epilepsy patients. Neurobiol Dis 5:151-176 (Pubitemid 28520950)
24. Miller CL, Diglisic S, Leister F, Webster M, Yolken RH (2004) Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. Biotechniques 36:628-633 (Pubitemid 38451647)
25. Morrison MR, Griffin WS (1981) The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain. Anal Biochem 113:318-324
26. Pardue S, Zimmerman AL, Morrison-Bogorad M (1994) Selective postmortem degradation of inducible heat shock protein 70 (hsp70) mRNAs in rat brain. Cell Mol Neurobiol 14:341-357
27. Perrett CW, Marchbanks RM, Whatley SA (1988) Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects. J Neurol Neurosurg Psychiatr 51:325-331 (Pubitemid 18097563)
28. Popova T, Mennerich D, Weith A, Quast K (2008) Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues. BMC Genomics 9:91
29. Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: Influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118:60-71 (Pubitemid 37238988)
30. Ragsdale DS, Miledi R (1991) Expressional potency of mRNAs encoding receptors and voltage-activated channels in the postmortem rat brain. Proc Natl Acad Sci USA 88:1854-1858 (Pubitemid 21916325)
31. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250-260 (Pubitemid 23060253)
32. Ross BM, Knowler JT, McCulloch J (1992) On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease. J Neurochem 58:1810-1819
33. Sajdel-Sulkowska EM, Majocha RE, Salim M, Zain SB, Marotta CA (1988) The postmortem Alzheimer brain is a source of structurally and functionally intact astrocytic messenger RNA. J Neurosci Methods 23:173-179 (Pubitemid 18060390)
34. Schramm M, Falkai P, Tepest R, Schneider-Axmann T, Przkora R, Waha A, Pietsch T, Bonte W, Bayer TA (1999) Stability of RNA transcripts in post-mortem psychiatric brains. J Neural Transm 106:329-335 (Pubitemid 29196936)
35. Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA (2006) Human postmortem tissue: What quality markers matter? Brain Res 1123:1-11
36. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, Watson SJ, Akil H, Bunney WE Jr (2004) Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55:346-352 (Pubitemid 38199983)
37. Vanderburg CR, Pfanni R, Tian D, Kiehl T-R, Hsi T, Hedley- Whyte ET, Frosch MP (2005) Factors influencing postmortem RNA integrity in human brain. J Neuropathol Exp Neurol 14:443
38. Vonsattel JP, Aizawa H, Ge P, DiFiglia M, McKee AC, MacDonald M, Gusella JF, Landwehrmeyer GB, Bird ED, Richardson EP Jr (1995) An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42-56
39. Yasojima K, McGeer EG, McGeer PL (2001) High stability of mRNAs postmortem and protocols for their assessment by RT-PCR. Brain Res Brain Res Protoc 8:212-218 (Pubitemid 33152947)
40. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18: S1-S2